Delivery Order SPE2DB20D3101-SPE2DB21FK1W8

Award Date 8/10/21
Potential Completion Date 8/11/21
Potential Value $2.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,361.71 Firm Fixed Price Delivery Order is for the provision of LUBIPROSTONE 8 MCG CAPSULE 60S, a pharmaceutical product, with an ultimate completion date of January 19, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, as the prime contractor, has a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Lubiprostone 24 MCG capsules for the Defense Logistics Agency (DLA). The $11,321.71 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of LUBIPROSTONE 8 MCG CAPSULE 60S, a pharmaceutical product. The contract has a ceiling value of $2,466.25 and an ultimate completion date of December 21, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award, valued at $1,827.94, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 60 capsules of the pharmaceutical product Lubiprostone 24 MCG. The contract is a Firm Fixed Price Delivery Order with a completion date of May 8, 2023. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,743.99 for the supply of 60 capsules of the medication Lubiprostone 24 MCG. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 7, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lubiprostone 24 MCG Capsule 60S, a pharmaceutical product, with a ceiling value of $14,705.70. The award date was January 4, 2022, and the ultimate completion date is January 5, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also does...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 24 MCG Capsule 60S. The contract has a firm fixed price of $3,951.52 and an ultimate completion date of August 19, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract is not designated with any...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,544.98, is for the delivery of Amitiza 8 MCG Capsule 60S, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,865.16 firm fixed-price delivery order contract is for the supply of LINZESS 145 MCG CAPSULE medical products. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,811.64, is a delivery order for AMITIZA 24 MCG CAPSULES 60S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK1W8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,523.23 firm-fixed-price delivery order is for 4554379657 LUBIPROSTONE 24 MCG CAPSULE 60S. There was no set-aside designation for this open competition award.

The contract serves as a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. Amerisourcebergen also holds a separate $750,000 Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These broad contracting vehicles enable efficient government procurement of essential drugs, devices, and other healthcare products to meet the needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:27 AM